Triple-negative breast cancer (TNBC) is a heterogeneous group of tumors defined by the lack of estrogen receptor alpha (ERα) and progesterone receptor expression, as well as the absence of human epidermal growth factor receptor 2 (HER2) amplification or overexpression. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.